Abstracts by keywords: CAD
Chronic coronary heart disease (CHD) contributes significantly to mortality, morbidity and loss of quality of life in Germany. Improved therapies and secondary and tertiary drug prevention have contributed to a significant decrease in CHD-related mortality in recent years. The improved survival with CHD and the growing proportion of the older population lead to an increase in the prevalence of the disease and its complications. The present publication is intended to present the morbidity, mortality and prevalence of chronic CHD in Germany and to identify the population groups that are particularly frequently affected by the disease. In addition, aspects of the burden of disease (quality of life, premature mortality and medical costs) are taken into account. Furthermore, gaps in care and potential for optimizing secondary and tertiary prevention for patients with chronic CHD should be identified.